|
KIAA1549 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.7954526754238E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.76403336382691E-12 |
| Normal-vs-Stage2 |
2.98140000465352E-08 |
| Normal-vs-Stage3 |
5.50720000047633E-07 |
| Normal-vs-Stage4 |
6.40629999999476E-05 |
| Stage1-vs-Stage2 |
1.689570E-01 |
| Stage1-vs-Stage3 |
9.083400E-03 |
| Stage1-vs-Stage4 |
5.300800E-01 |
| Stage2-vs-Stage3 |
6.617900E-03 |
| Stage2-vs-Stage4 |
1.432800E-01 |
| Stage3-vs-Stage4 |
3.490600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.08140180038663E-11 |
| Normal-vs-AfricanAmerican |
4.17750000000217E-05 |
| Normal-vs-Asian |
4.13549999800367E-08 |
| Caucasian-vs-AfricanAmerican |
1.680010E-01 |
| Caucasian-vs-Asian |
1.808210E-01 |
| AfricanAmerican-vs-Asian |
7.426000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.06749975315302E-10 |
| Normal-vs-Female |
4.7839510131098E-13 |
| Male-vs-Female |
9.313600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.7201574326341E-12 |
| Normal-vs-Age(41-60Yrs) |
1.93509985813023E-10 |
| Normal-vs-Age(61-80Yrs) |
4.70580000522247E-08 |
| Normal-vs-Age(81-100Yrs) |
5.851600E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.494000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.108400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.999040E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.753600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.642400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.450600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.29739999965572E-07 |
| Classical-VS-Follicular |
2.840400E-02 |
| Classical-VS-Other |
3.601600E-01 |
| Classical-VS-Normal |
3.35287353436797E-13 |
| Tall-VS-Follicular |
2.90889999865485E-08 |
| Tall-VS-Other |
2.079800E-01 |
| Tall-VS-Normal |
6.306500E-02 |
| Follicular-VS-Other |
2.687800E-02 |
| Follicular-VS-Normal |
6.81965595106249E-12 |
| Other-VS-Normal |
3.655800E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.75748304798162E-12 |
| Normal-vs-N1 |
3.92679999960954E-07 |
| N0-vs-N1 |
9.148400E-02 |
|
|
